Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.

Tumor-Associated Trypsinogen-2 (Trypsinogen-2) Activates Procollagenases (MMP-1, -8, -13) and Stromelysin-1 (MMP-3) and Degrades Type I Collagen

Abstract

A critical step in cancer growth and metastasis is the dissolution of the extracellular matrix surrounding the malignant tumor, which leads to tumor cell invasion and dissemination. Type I collagen degradation involves the initial action of collagenolytic matrix metalloproteinases (MMP-1, -8, and -13) activated by MMP-3 (stromelysin-1). The role of interactive matrix serine proteinases (MSPs), including tumor-associated trypsinogens, has been unclear in collagenolysis. Now, we provide evidence that the major isoenzyme of human tumor-associated trypsinogens, trypsin-2, can directly activate three collagenolytic proMMPs as well as proMMP-3. These proMMP activations are inhibited by tumor-associated trypsin inhibitor (TATI). Furthermore, we demonstrate that trypsin-2 efficiently degrades native soluble type I collagen, which can be inhibited by TATI. However, cell culture studies showed that trypsin-2 transfection into the HSC-3 cell line did not result in MMP-1, -3, -8, and -13 activation but affected MMP-3 and -8 production at the protein level. These findings indicate that human trypsin-2 can be regarded as a potent tumor-associated matrix serine protease capable of being the initial activator of the collagenolytic MMP activation network as well as directly attacking type I collagen.

Overview

Integrity signals

Registry

Crossref · 10.1021/bi020582s

Cites

30 of 30 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 30 references

Research works printed but not linked: 37

  1. Roberts R., 1995, Crit. Rev. Eukaryotic Gen. Expr., 5
  2. Birkedal-Hansen H., 1995, Curr. Opin. Cell. Biol. 7, 728−735
  3. Springman E. B., 1990, 87, 364−368
  4. Van Wart H. E., 1990, Proc. Natl. Acad. Sci. U.S.A. 87, 5578−5582
  5. Neurath H., 1984, Science 224, 350−357
  6. Sheele G., 1981, Gastroenterology 80, 461−473
  7. Wiegand U., 1993, Gene 136, 167−175
  8. Stenman U. H., 1988, Biol. Chem. Hoppe-Seyler, 369, 14
  9. Koivunen E., 1990, Cancer Res. 50, 2375−2378
  10. Kato Y., 1998, Eur. J. Cancer, 34
  11. Miyata S., 1998, Clin. Exp. Metastasis 16, 613−622
  12. Stenman U. H., 1990, Scand. J. Clin. Lab. Invest. Suppl., 201, 101
  13. Thomas G. T., 1999, Oral Oncol. 35, 227−233
  14. Suzuki K., 1990, Biochemistry 29, 10261−10270
  15. Sang Q. X., 1995, Biochim. Biophys. Acta, 1251, 108
  16. Wilhelm S. M., 1987, Proc. Natl. Acad. Sci. U.S.A. 84, 6725−6727
  17. Knäuper V., 1996, J. Biol. Chem., 271
  18. Lindy O., 1997, Arthritis Rheum. 40, 1391−1399
  19. Sorsa T., 1994, Ann. N.Y. Acad. Sci. 6, 112−131
  20. Boyum A., 1968, Scand. J. Clin. Lab. Invest. Suppl., 97, 89
  21. Hibbs M. S., 1984, Coll. Relat. Res. 4, 467−477
  22. Konttinen Y. T., 1998, Matrix Biol. 17, 585−601
  23. Baumann M., 1990, Anal. Biochem. 190, 198−208
  24. Bergmann U., 1989, J. Clin. Chem. Clin. Biochem., 27
  25. Itkonen O., 1990, J. Lab. Clin. Med., 115
  26. Koivunen E., 1991, Cancer Res. 51, 2107−2112
  27. Craik C. S., 1985, Science 228, 291−297
  28. Nagase H., 1990, Biochemistry 29, 5783−5789
  29. Tschesche H., 1992, Matrix Suppl. 1, 245−255
  30. Weiss S. J., 1989, N. Engl. J. Med., 320
  31. Cole A. A., 1996, J. Biol. Chem., 271
  32. Prikk K., 2001, 33, 437−444
  33. Kim M. H., 2001, Anticancer Res., 21, 50
  34. Bachmeier B. E., 2000, Biol. Chem. 381, 509−516
  35. Herman M. P., 2001, Circulation 104
  36. Kafienah W., 1998, Biochem. J., 220
  37. Abbreviations MMP, matrix metalloproteinase

Cited by

See all 111

Metadata

Authors
Moilanen, M., Sorsa, T., Stenman, M., Nyberg, P., Lindy, O., Vesterinen, J., Paju, A., Konttinen, Y. T., Stenman, U.-H., & Salo, T.
Affiliations
Oulu University Hospital (FI)
Corresponding author
Salo, Tuula
Venue
Biochemistry
Published
2003-04-12
Volume
42
Issue
18
Pages
5414-5420
ISSN
  • 0006-2960 (ISSN-L)
  • 1520-4995
OpenAlex
W1967869198
Cited by
111
References
30
Citations by year
2026: 1 · 2025: 3 · 2024: 1 · 2023: 6 · 2022: 3 · 2021: 3 · 2020: 5 · 2019: 1 · 2018: 3 · 2017: 3 · 2016: 2 · 2014: 3 · 2013: 5 · 2012: 6
FWCI
4.86
Type
journal article
Language
en
Open access
closed
Locations
  • Biochemistry (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Protease and Inhibitor Mechanisms
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Peptidase Inhibition and Analysis
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › TGF-β signaling in diseases
Keywords
trypsinogen-2, matrix metalloproteinase activation, MMP-1, MMP-8, MMP-13, MMP-3, stromelysin-1, type I collagen degradation, tumor-associated trypsin inhibitor, extracellular matrix degradation, tumor invasion, HSC-3 cells
MeSH terms
Enzyme Activation, Enzyme Precursors, Extracellular Matrix, Humans, Serine Endopeptidases, Trypsin, Trypsin Inhibitor, Kazal Pancreatic, Trypsinogen, Tumor Cells, Cultured, Blotting, Western, Polymerase Chain Reaction, Collagenases, DNA Primers, Matrix Metalloproteinase 3, Matrix Metalloproteinase 1, Matrix Metalloproteinase 8, Collagen Type I, Matrix Metalloproteinase 13

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Tumor-Associated Trypsinogen-2 (Trypsinogen-2) Activates Procollagenases (MMP-1, -8, -13) and Stromelysin-1 (MMP-3) and Degrades Type I Collagen. https://app.cochat.ai/papers/10.1021/bi020582s
The paper
Moilanen, M., Sorsa, T., Stenman, M., Nyberg, P., Lindy, O., Vesterinen, J., Paju, A., Konttinen, Y. T., Stenman, U.-H., & Salo, T. (2003). Tumor-Associated Trypsinogen-2 (Trypsinogen-2) Activates Procollagenases (MMP-1, -8, -13) and Stromelysin-1 (MMP-3) and Degrades Type I Collagen. Biochemistry. https://doi.org/10.1021/bi020582s

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.